Board meeting of GlaxoSmithKline Pakistan Limited to be held on August 26, 2016

Karachi, GlaxoSmithKline Pakistan Limited informed Pakistan Stock Exchange that the board meeting of the company is scheduled to be held on August 26, 2016 at Karachi. The agenda of the meeting shall be consideration of half yearly accounts for the period ended June 30, 2016.

Further, the closed period of the company shall be from August 19, 2016 to August 26, 2016 (both days inclusive).

Glaxo Smith Kline Pakistan Limited is incorporated in Pakistan as a limited liability company. The company is engaged in manufacturing and marketing of research based pharmaceutical and consumer products. The company is a subsidiary of S.R. One International B.V., Netherlands, whereas its ultimate parent company is GlaxoSmithKline Plc, UK. The stocks of the company are quoted on the Karachi and Lahore Stock Exchanges of Pakistan.

The company was created on January 1, 2001 through the merger of SmithKline and French of Pakistan Limited, Beecham Pakistan Private Limited and Glaxo Wellcome Pakistan Limited. Some of the pharmaceutical brands produced by the company include Augmentin, Seretide, Amoxil, Velosef, Zantac and Calpol and renowned consumer healthcare brands, which include Panadol, Horlicks, Aquafresh, Macleans and ENO.

The symbol “GLAXO” is being used by the stock exchanges for the shares of GlaxoSmithKline Pakistan Limited.

You May Also Like